OneOme provides RightMed® test to Ochsner Health, advancing personalized precision medicine for employees.

MINNEAPOLIS, MN - April 5, 2023

Ochsner Health, one of the leading nonprofit, multi-specialty health care systems in the Gulf South, has contracted with OneOme® to provide pharmacogenomic (PGx) testing for their patients and covered employees and family members through OneOme’s RightMed® solution.

Pharmacogenomics (PGx) is the study of how genetics may affect an individual’s response to medications. PGx testing analyzes a patient's DNA to give doctors and pharmacists information that may help them optimize medication selection for each patient, reduce trial and error in the prescribing process and decrease the likelihood of adverse drug reactions. Together, these efforts can lower potential healthcare costs and vastly improve patient experience and outcomes.

“These tests are innovative, but we are using peer-reviewed and evidence-based guidelines available for the drug/gene interactions for which we are testing,” said Catherine Oliver, PharmD, BCPS, DPLA, CPGx, System Director of Clinical Pharmacy Services for Ochsner Health. “Even if the patient doesn’t use the medications at the time of the test, it helps providers make decisions about individual care going forward.”

PGx testing, available as an included service in the Ochsner Health Employee benefit plan for any employee/patient, will be ordered by an Ochsner provider who would find it useful in the clinical management of the patient.

“We are enthusiastic to see RightMed testing be accessible, available, and actionable for providers, patients, and employees within the Ochsner Health system,” said James Kelley, MD, PhD, Chief Medical Officer at OneOme. “This initiative shows their continued commitment to personalized medicine and best health outcomes.”

OneOme is a market leader in precision medicine, providing pharmacogenetic solutions, population-level analyses and clinical decision support solutions. Through its services, OneOme aims to impact patient safety, reduce the overall cost of care, and improve patients' health outcomes. Co-founded by the Mayo Clinic, from its headquarters in Minneapolis, OneOme offers its services to clients around the world. By using the proven research and science of pharmacogenomics, the company is making a positive, noticeable difference in patients' lives and works closely with its partners, including health systems, health plans, and employers, to realize these benefits across the healthcare system. For more information, visit

Ochsner Health is an integrated healthcare system with a mission to Serve, Heal, Lead, Educate and Innovate. Celebrating 80 years in 2022, it leads nationally in cancer care, cardiology, neurosciences, liver and kidney transplants and pediatrics, among other areas. Ochsner is consistently named both the top hospital and top children’s hospital in Louisiana by U.S. News & World Report. The not-for-profit organization is inspiring healthier lives and stronger communities. Its focus is on preventing diseases and providing patient-centered care that is accessible, affordable, convenient, and effective. Ochsner Health pioneers new treatments, deploys emerging technologies and performs groundbreaking research, including 4,000 patients enrolled in 685 clinical studies in 2022. It has more than 38,000 employees and over 4,600 employed and affiliated physicians in over 90 medical specialties and subspecialties. It operates 48 hospitals and more than 370 health and urgent care centers across Louisiana, Mississippi, Alabama and the Gulf South; and its cutting-edge Connected Health digital medicine program is caring for patients beyond its walls. To learn more, visit